Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

[1]  Po-Hsuan Cameron Chen,et al.  Deep learning models for histologic grading of breast cancer and association with disease prognosis , 2022, npj Breast Cancer.

[2]  L. Solorzano,et al.  Improved breast cancer histological grading using deep learning. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  G. Calip,et al.  Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. , 2021, JAMA oncology.

[4]  A. Nassar,et al.  Oncotype DX and Prosigna in breast cancer patients: A comparison study. , 2021, Cancer treatment and research communications.

[5]  E. Winer,et al.  Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center , 2020, Breast Cancer Research and Treatment.

[6]  Jordan H Creed,et al.  MatSurv: Survival analysis and visualization in MATLAB , 2020, J. Open Source Softw..

[7]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[8]  Ronnachai Jaroensri,et al.  Artificial intelligence in digital breast pathology: Techniques and applications , 2019, Breast.

[9]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[10]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[11]  A. Madabhushi,et al.  Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology , 2019, Nature Reviews Clinical Oncology.

[12]  P. V. van Diest,et al.  Significant inter‐ and intra‐laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands , 2019, International journal of cancer.

[13]  Daniel Racoceanu,et al.  Deep Learning for Semantic Segmentation vs. Classification in Computational Pathology: Application to Mitosis Analysis in Breast Cancer Grading , 2019, Front. Bioeng. Biotechnol..

[14]  A. Madabhushi,et al.  Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers , 2018, Laboratory Investigation.

[15]  A. Madabhushi,et al.  Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer , 2018, BMC Cancer.

[16]  Andrew Janowczyk,et al.  A deep learning based strategy for identifying and associating mitotic activity with gene expression derived risk categories in estrogen receptor positive breast cancers , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[17]  Yan Li,et al.  Computer-aided prognosis on breast cancer with hematoxylin and eosin histopathology images: A review , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[18]  George Lee,et al.  Image analysis and machine learning in digital pathology: Challenges and opportunities , 2016, Medical Image Anal..

[19]  Anant Madabhushi,et al.  Emerging Themes in Image Informatics and Molecular Analysis for Digital Pathology. , 2016, Annual review of biomedical engineering.

[20]  Andrew Janowczyk,et al.  Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images , 2016, Scientific Reports.

[21]  Nabil Wasif,et al.  Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma , 2015, Annals of Surgical Oncology.

[22]  Valerie F. Reyna,et al.  Improving communication of breast cancer recurrence risk , 2012, Breast Cancer Research and Treatment.

[23]  Rohit Bhargava,et al.  Histopathologic variables predict Oncotype DX™ Recurrence Score , 2008, Modern Pathology.

[24]  Hanina Hibshoosh,et al.  Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study , 2006, Modern Pathology.

[25]  E. Perez,et al.  E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer , 2005 .

[26]  I. Ellis,et al.  Expert Commentary. , 2002, Histopathology.

[27]  P. Ravdin,et al.  Prognostic factors in early breast carcinoma , 1994, Cancer.

[28]  Franz Aurenhammer,et al.  Voronoi diagrams—a survey of a fundamental geometric data structure , 1991, CSUR.

[29]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.

[30]  Hannah Gilmore.  Pediatric Pathology , 2017, Modern Pathology.

[31]  M. Fernö,et al.  Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group. , 2000, Acta oncologica.